Zentalis Pharmaceuticals, Inc.
ZNTL · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$27 | -$27 | -$48 | -$47 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $5 | $6 | $6 | $31 |
| Change in WC | -$1 | -$8 | $2 | -$7 |
| Other Non-Cash | -$4 | -$6 | $7 | -$17 |
| Operating Cash Flow | -$27 | -$35 | -$33 | -$40 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $1 | $0 | $0 |
| Inv. Purchases | -$50 | -$40 | -$20 | -$39 |
| Inv. Sales/Matur. | $78 | $70 | $60 | $72 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $28 | $30 | $40 | $32 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $0 | $0 | $0 | $0 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $1 | -$4 | $8 | -$7 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $40 | $45 | $37 | $44 |
| End Cash | $42 | $40 | $45 | $37 |
| Free Cash Flow | -$27 | -$35 | -$33 | -$40 |